New York, May 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Xerostomia (Dry Mouth) Therapeutics Industry" - https://www.reportlinker.com/p06033322/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Xerostomia (Dry Mouth) Therapeutics Market to Reach $1 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Xerostomia (Dry Mouth) Therapeutics estimated at US$704.1 Million in the year 2022, is projected to reach a revised size of US$1 Billion by 2030, growing at aCAGR of 4.6% over the period 2022-2030. Over-the-Counter, one of the segments analyzed in the report, is projected to record 4.7% CAGR and reach US$603.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Prescription segment is readjusted to a revised 4.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $191.8 Million, While China is Forecast to Grow at 7.4% CAGR
The Xerostomia (Dry Mouth) Therapeutics market in the U.S. is estimated at US$191.8 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$209.5 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 3.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.
Select Competitors (Total 36 Featured)
- 3M company
- Advanz Pharma Corp. Limited
- Bausch Health Companies Inc.
- Fresenius SE & Co. KGaA
- GlaxoSmithKline PLC
- Hikma Pharmaceuticals PLC
- Lupin Limited
- Parnell Pharmaceuticals Inc.
- Pharmascience Inc (Pendopharm)
- Quest Products Inc.
Read the full report: https://www.reportlinker.com/p06033322/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Xerostomia (Dry Mouth) Therapeutics - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for
Over-the-Counter by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Over-the-Counter by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Over-the-Counter by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Prescription by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Prescription by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 9: World 16-Year Perspective for Prescription by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Dentifrices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Dentifrices by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 12: World 16-Year Perspective for Dentifrices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for
Salivary Stimulants by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Salivary Stimulants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 15: World 16-Year Perspective for Salivary Stimulants by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Salivary Substitutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Salivary Substitutes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 18: World 16-Year Perspective for Salivary Substitutes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 19: World Xerostomia (Dry Mouth) Therapeutics Market
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2030
III. MARKET ANALYSIS
UNITED STATES
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2023 (E)
Table 20: USA Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 21: USA Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 22: USA 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 23: USA Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 24: USA Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 25: USA 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
CANADA
Table 26: Canada Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 27: Canada Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 28: Canada 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 29: Canada Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 30: Canada Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 31: Canada 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
JAPAN
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 32: Japan Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 33: Japan Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 34: Japan 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 35: Japan Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 36: Japan Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 37: Japan 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
CHINA
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 38: China Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 39: China Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 40: China 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 41: China Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 42: China Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 43: China 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
EUROPE
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 44: Europe Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 45: Europe Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 46: Europe 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2014, 2023 & 2030
Table 47: Europe Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 48: Europe Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 49: Europe 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 50: Europe Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 51: Europe Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 52: Europe 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
FRANCE
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 53: France Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 54: France Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 55: France 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 56: France Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 57: France Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 58: France 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
GERMANY
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 59: Germany Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 60: Germany Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 61: Germany 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Type - Percentage Breakdown of Value
Sales for Over-the-Counter and Prescription for the Years 2014,
2023 & 2030
Table 62: Germany Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 63: Germany Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 64: Germany 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Percentage Breakdown
of Value Sales for Dentifrices, Salivary Stimulants and
Salivary Substitutes for the Years 2014, 2023 & 2030
ITALY
Table 65: Italy Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 66: Italy Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 67: Italy 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 68: Italy Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 69: Italy Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 70: Italy 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
UNITED KINGDOM
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2023 (E)
Table 71: UK Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 72: UK Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 73: UK 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 74: UK Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 75: UK Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 76: UK 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
SPAIN
Table 77: Spain Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 78: Spain Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 79: Spain 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 80: Spain Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 81: Spain Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 82: Spain 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
RUSSIA
Table 83: Russia Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 84: Russia Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 85: Russia 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 86: Russia Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 87: Russia Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 88: Russia 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 89: Rest of Europe Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Type -
Over-the-Counter and Prescription - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 90: Rest of Europe Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 91: Rest of Europe 16-Year Perspective for Xerostomia
(Dry Mouth) Therapeutics by Type - Percentage Breakdown of
Value Sales for Over-the-Counter and Prescription for the Years
2014, 2023 & 2030
Table 92: Rest of Europe Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 93: Rest of Europe Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 94: Rest of Europe 16-Year Perspective for Xerostomia
(Dry Mouth) Therapeutics by Product Segment - Percentage
Breakdown of Value Sales for Dentifrices, Salivary Stimulants
and Salivary Substitutes for the Years 2014, 2023 & 2030
ASIA-PACIFIC
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Asia-Pacific for
2023 (E)
Table 95: Asia-Pacific Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2022 through 2030 and % CAGR
Table 96: Asia-Pacific Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 97: Asia-Pacific 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Geographic Region - Percentage Breakdown
of Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2014, 2023 & 2030
Table 98: Asia-Pacific Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Type -
Over-the-Counter and Prescription - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 99: Asia-Pacific Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 100: Asia-Pacific 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Type - Percentage Breakdown of Value
Sales for Over-the-Counter and Prescription for the Years 2014,
2023 & 2030
Table 101: Asia-Pacific Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 102: Asia-Pacific Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 103: Asia-Pacific 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Percentage Breakdown
of Value Sales for Dentifrices, Salivary Stimulants and
Salivary Substitutes for the Years 2014, 2023 & 2030
AUSTRALIA
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Australia for 2023
(E)
Table 104: Australia Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 105: Australia Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 106: Australia 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Type - Percentage Breakdown of Value
Sales for Over-the-Counter and Prescription for the Years 2014,
2023 & 2030
Table 107: Australia Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 108: Australia Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 109: Australia 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Percentage Breakdown
of Value Sales for Dentifrices, Salivary Stimulants and
Salivary Substitutes for the Years 2014, 2023 & 2030
INDIA
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in India for 2023 (E)
Table 110: India Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 111: India Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 112: India 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2014, 2023 &
2030
Table 113: India Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 114: India Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 115: India 16-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2014, 2023 & 2030
SOUTH KOREA
Table 116: South Korea Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Type -
Over-the-Counter and Prescription - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 117: South Korea Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 118: South Korea 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Type - Percentage Breakdown of Value
Sales for Over-the-Counter and Prescription for the Years 2014,
2023 & 2030
Table 119: South Korea Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 120: South Korea Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 121: South Korea 16-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Percentage Breakdown
of Value Sales for Dentifrices, Salivary Stimulants and
Salivary Substitutes for the Years 2014, 2023 & 2030
REST OF ASIA-PACIFIC
Table 122: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Xerostomia (Dry Mouth) Therapeutics by Type -
Over-the-Counter and Prescription - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 123: Rest of Asia-Pacific Historic Review for Xerostomia
(Dry Mouth) Therapeutics by Type - Over-the-Counter and
Prescription Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 124: Rest of Asia-Pacific 16-Year Perspective for
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033322/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
